Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Richette

Showing results (21-30 of 307) with videos related to

Pageof 31
Sort By:
Expert Opinion on Pharmacotherapy|July 11, 2017
Current and future therapies for goutTristan Pascart, Pascal Richette
Current Pharmaceutical Design|January 17, 2018
Colchicine in Gout: An UpdateTristan Pascart, Pascal Richette
Nature Clinical Practice. Rheumatology|August 26, 2006
Successful treatment with rasburicase of a tophaceous gout in a patient allergic to allopurinolPascal Richette, Thomas Bardin
Presse Medicale (Paris, France : 1983)|July 9, 2011
[Basic calcium phosphate crystal deposition disease]Thomas Bardin, Pascal Richette
La Revue Du Praticien|February 11, 2022
[Hand Osteoarthritis]Pascal Richette, Augustin Latourte
Nature Reviews. Rheumatology|October 12, 2018
Hyperferritinaemia and hyperuricaemia - a causal connection?Pascal Richette, Augustin Latourte
BMC Medicine|July 4, 2017
Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment optionsThomas Bardin, Pascal Richette
Current Opinion in Rheumatology|January 3, 2019
The role of febuxostat in goutThomas Bardin, Pascal Richette
Current Opinion in Rheumatology|November 3, 2009
Nephrogenic systemic fibrosisThomas Bardin, Pascal Richette
Current Opinion in Rheumatology|January 15, 2014
Definition of hyperuricemia and gouty conditionsThomas Bardin, Pascal Richette
Pageof 31

Showing results (21-30 of 307) with videos related to

Sort By:
Pageof 31
Expert Opinion on Pharmacotherapy|July 11, 2017
Current and future therapies for goutTristan Pascart, Pascal Richette
Current Pharmaceutical Design|January 17, 2018
Colchicine in Gout: An UpdateTristan Pascart, Pascal Richette
Nature Clinical Practice. Rheumatology|August 26, 2006
Successful treatment with rasburicase of a tophaceous gout in a patient allergic to allopurinolPascal Richette, Thomas Bardin
Presse Medicale (Paris, France : 1983)|July 9, 2011
[Basic calcium phosphate crystal deposition disease]Thomas Bardin, Pascal Richette
La Revue Du Praticien|February 11, 2022
[Hand Osteoarthritis]Pascal Richette, Augustin Latourte
Nature Reviews. Rheumatology|October 12, 2018
Hyperferritinaemia and hyperuricaemia - a causal connection?Pascal Richette, Augustin Latourte
BMC Medicine|July 4, 2017
Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment optionsThomas Bardin, Pascal Richette
Current Opinion in Rheumatology|January 3, 2019
The role of febuxostat in goutThomas Bardin, Pascal Richette
Current Opinion in Rheumatology|November 3, 2009
Nephrogenic systemic fibrosisThomas Bardin, Pascal Richette
Current Opinion in Rheumatology|January 15, 2014
Definition of hyperuricemia and gouty conditionsThomas Bardin, Pascal Richette
Pageof 31